MikiY., SwensenJ., Shattuck-EidensD., FutrealP.A., Haish-manK., TavtigianS., LiuQ., CochranC., BennetL.M., DingW.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.Science, 266: 66–71, 1994.
EastonD.F., FordD., BishopD.T.: Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Am J Hum Genet, 56: 265–271, 1995.
4.
FordD., EastonD.F., BishopD.T., NarodS.A., GoldgarD.E.: Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.Lancet, 343: 692–695, 1994.
5.
FordD., EastonD.F.: The genetics of breast and ovarian cancer.Br J Cancer, 72: 805–812, 1995.
6.
EastonD.F., BishopD.T., FordD., CrockfordG.P.: Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Linkage Consortium.Am J Hum Genet, 52: 678–701, 1993.
7.
VerhoogL.C., BrekelmansC.T., SeynaeveC., Meijers-HeijboerE.J., KlijnJ.G.: Contralateral breast cancer risk is influenced by the age at onset in BRCA-1 associated breast cancer.Br J Cancer, 83: 384–386, 2000.
8.
FrankT.S., ManleyS.A., OlopadeO.I., CummingsS., GarberJ.E., BernhardtB., AntmanK., RussoD., WoodM.E., MullineanL., IsaacsC., PeshkinB., BuysS., VenneV., RawleyP.T., LoaderS., OffetK., RobsonM., HempelH., BremerD., WinerE.P., ClarkS., WeberB., StrongL.L., ThomasA.: Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk.J Clin Oncol, 16: 2417–2425, 1998.
9.
FisherB., ConstantinoP., WickerhamD.L., RedmondC.K., Ka-vanahM., CeoninW.M., VogelV., RobidouxA., DimitrovN., AtkinsJ., DalyM., WieandS., Tan-ChiuE., FordL., WolmarkN.: Tamoxifen for prevention of breast cancer: report of the National Surgical Breast and Bowel Project P-1 study.J Natl Cancer Inst, 90: 1371–1388, 1998.
10.
PowlesT., EelesR., AshleyS., EastonD., ChangJ., DowsettM., TidyA., ViggersJ., DaveyJ.: Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomized chemoprevention trial.Lancet, 352: 98–101, 1998.
11.
VeronesiU., MaisonneuveP., CostaA., SacchiniV., MaltoniC., RobertsonC., RotmenszN., BoyleP.: Prevention of breast cancer with tamoxifen: preliminary findings from the Italian randomised trial amongst hysterectomised women.Lancet, 352: 93–97, 1998.
12.
JohansssonO.T., RanstamJ., BorgA., OlssonH.: Survival of BRCA 1 breast and ovarian cancer patients: a population based study from Southern Sweden.J Clin Oncol, 16: 397–404, 1998.
13.
AmesJ.E., TruteL., WhiteD., SoutheyM.C., HammetF., TesorieroA., HutchinsA.M., DiteG.S., McCredieM.R., GilesG.G., HopperJ.L.: Distinct molecular pathogenesis of early-onset breast cancers in BRCA1 and BRCA 2 mutation carriers: population based study.Cancer Res, 59: 2011–2017, 1999.
14.
OsinO., CrookT., PowlesT., PetoJ., GustersonB.: Hormone status of in situ cancer in BRCA 1 and BRCA 2 mutation carriers.Lancet, 351: 1487, 1998.
15.
WillemsenH.W., KaasR., PeterseJ.H., RutgersE.J.: Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy.Eur J Surg Oncol, 24: 331–332, 1998.
16.
HartmannL.C., SchaidD., SellerT., McDonnelS., WoodsJ., Sit-taD., FrostM., CouchF., JenkinsR.: Bilateral prophylactic mastectomy in BRCA 1, 2 carriers.Proc Am Assoc Cancer Res, 41: 222–223, 2000.
17.
HartmannL.C., SchaidD.J., WoodsJ.E., CrottyT.P., MyersJ.L., ArnoldP.G., PettyP.M., SellerT.A., JohnsonJ.L., McDonnelS.K., FrostM.H., JenkinsR.B.: Efficacy of bilateral mastectomy in women with a family history of breast cancer.N Engl J Med, 340: 77–84, 1999.
18.
GoldmanL.D., GoldwynR.M.: Some anatomical considerations of subcutaneous mastectomy.Plast Reconstr Surg, 51: 502–508, 1973.
19.
ZieglerL.D., KrollS.S.: Primary breast cancer after prophylactic mastectomy.Am J Clin Oncol, 14: 451–454, 1991.
20.
GoodnightJ.E.Jr., QuaglianaJ.M., MortonD.L.: Failure of subcutaneous mastectomy to prevent the development of breast cancer.J Surg Oncol, 26: 198–201, 1984.
21.
HollebA.I., MontgomeryR., FarrowJ.H.: The hazard of incomplete simple mastectomy.Surg Gynecol Obstet, 121: 819–922, 1965.
22.
JamesonM.B., RobertE., NixonJ., ProbertJ.C., BraatvedtG.D.: Metastatic breast cancer 42 years after subcutaneous mastectomy.Clin Oncol (R Coll Radiol), 9: 119–121, 1997.
23.
WillemsenH.W., KaasR., PeterseJ.H., RutgersE.J.: Breast carcinoma in residual breast tissue after prophylactic bilateral subcutaneous mastectomy.Eur J Surg Oncol, 24: 331–338, 1993.
24.
Meijers-HeijboerE.J., VerhoogL.C., BrekelmansC.T., SeynaeveC., Tilanus-LinthorstM.M., WagnerA., DukelL., DévileeP., van den OuwelandA.M., van GeelA.N., KlijnJ.G.: Presymptomatic DNA testing and prophylactic surgery in families with a BRCA 1 or BRCA 2 mutation.Lancet, 355: 2015–2020, 2000.
25.
WagnerT.M., MoslingerR., LangbauerG., AhnerR., Fleis-chmanE., AuterithA., FriedmanA., HelbichT., ZielinskiC., PittermannE., SeifertM., OefnerP.: Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. Austrian Hereditary Breast and Ovarian Cancer Group.Br J Cancer, 82: 1249–1253, 2000.
26.
LynchH.T., LemonS.J., DurhamS.T., TinleyS.T., ConnollyC., LynchJ.F., SurdamJ., OrinionE., Slominski-CasterS., WatsonP., LermanC., ToninP., LenoirG., SerovaO., NarodS.: A descriptive study of BRCA 1 testing and reactions to disclosure of test results.Cancer, 79: 2219–2228, 1997.
27.
KelseyJ.L., GammonM.D.The epidemiology of breast cancer.CA Cancer J Clin, 41: 147–165, 1991.
28.
RebbeckT.R., LevinA.M., EisenA., SnyderC., WatsonP., Cannon-AlbrightL., IsaacsC., OlopadeO., GarberJ., GodwinA.K., DalyM.B., NarodS.A., NeuhausenS.L., LynchH.T., WeberB.: Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers.J Natl Cancer Inst, 91: 1475–1479, 1999.
29.
SchragD., KuntzK.M., GarberJ.E., WeeksJ.C.: Decision analysis - effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 and BRCA2 mutations.N Engl J Med, 336: 1465–1471, 1997.
30.
GrannV.R., WhangW., JacobsonJ.S.: Decision analysis of chemoprevention versus prophylactic surgery in BRCA1 and BRCA2 positive patients.Proc Am Soc Clin Oncol: abstract 2411, 1999.
31.
LallooF., EvansD.G.R., HowellA.: Familial breast cancer clinics - good value or waste of resources? In: Challenges in breast cancer, FentimanI.S. (Ed), pp. 56–71, Blackwell Science, Oxford, 1999.
